Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 32.48% vs 29.17% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 37.69% vs 11.71% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 21.67% vs 90.48% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -28.34% vs 62.66% in Mar 2024
Compare Profit and Loss Results of Astrazeneca Phar
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,716.00
1,476.00
240.00
16.26%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,716.00
1,476.00
240.00
16.26%
Expenditure (Ex Depriciation)
Stock Adjustments
-332.00
12.00
-344.00
-2,866.67%
Raw Materials Consumed
1,295.00
574.00
721.00
125.61%
Power & Fuel Cost
5.00
50.00
-45.00
-90.00%
Employee Cost
257.00
261.00
-4.00
-1.53%
Operating Expenses
18.00
112.00
-94.00
-83.93%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
93.00
42.00
51.00
121.43%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
13.00
22.00
-9.00
-40.91%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,462.00
1,154.00
308.00
26.69%
Operating Profit (PBDIT) excl Other Income
253.00
322.00
-69.00
-21.43%
Other Income
40.00
20.00
20.00
100.00%
Operating Profit (PBDIT)
294.00
342.00
-48.00
-14.04%
Interest
1.00
8.00
-7.00
-87.50%
Profit before Depriciation and Tax
293.00
334.00
-41.00
-12.28%
Depreciation
39.00
65.00
-26.00
-40.00%
Profit Before Taxation & Exceptional Items
253.00
268.00
-15.00
-5.60%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
156.00
345.00
-189.00
-54.78%
Provision for Tax
40.00
85.00
-45.00
-52.94%
Profit After Tax
115.00
259.00
-144.00
-55.60%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
578.00
747.00
-169.00
-22.62%
Profit Available for appropriations
693.00
1,006.00
-313.00
-31.11%
Appropriations
693.00
1,006.00
-313.00
-31.11%
Equity Dividend (%)
1600%
120%
1,480.00
Earnings Per Share
46.3
202.2
-155.90
-77.10%
Profit And Loss - Net Sales
Net Sales 1,716.29 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 32.48% vs 29.17% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 253.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.69% vs 11.71% in Mar 2024
Profit And Loss - Interest
Interest 1.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.67% vs 90.48% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 115.74 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -28.34% vs 62.66% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
